The assay being used is the PubChem BioAssay, specifically the qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. This particular assay falls under the class of confirmatory assays and has been assigned a homologous single protein target. Additionally, it possesses certain properties that make it distinguishable, which includes its assay category being confirmatory and its assay type description being Functional. Does this assay show the effectiveness of the molecule?